Tributary Capital Management LLC Sells 644 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Tributary Capital Management LLC reduced its stake in Molina Healthcare, Inc. (NYSE:MOH) by 21.3% in the first quarter, Holdings Channel.com reports. The fund owned 2,378 shares of the company’s stock after selling 644 shares during the period. Tributary Capital Management LLC’s holdings in Molina Healthcare were worth $977,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC lifted its stake in Molina Healthcare by 35.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,734 shares of the company’s stock worth $1,123,000 after purchasing an additional 722 shares in the last quarter. Atlas Capital Advisors LLC increased its stake in Molina Healthcare by 663.0% in the 1st quarter. Atlas Capital Advisors LLC now owns 412 shares of the company’s stock worth $169,000 after acquiring an additional 358 shares during the last quarter. Gateway Investment Advisers LLC increased its stake in Molina Healthcare by 1.6% in the 1st quarter. Gateway Investment Advisers LLC now owns 19,459 shares of the company’s stock worth $7,994,000 after acquiring an additional 314 shares during the last quarter. AdvisorNet Financial Inc boosted its position in shares of Molina Healthcare by 12.4% during the 1st quarter. AdvisorNet Financial Inc now owns 2,545 shares of the company’s stock valued at $1,046,000 after acquiring an additional 281 shares during the last quarter. Finally, Ballentine Partners LLC grew its holdings in shares of Molina Healthcare by 2.0% during the first quarter. Ballentine Partners LLC now owns 3,024 shares of the company’s stock worth $1,242,000 after purchasing an additional 60 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Molina Healthcare

In other news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the transaction, the director now owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the completion of the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the sale, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The disclosure for this sale can be found here. 1.11% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Barclays cut their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a research note on Thursday, April 25th. Robert W. Baird assumed coverage on Molina Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $405.00 price target on the stock. Stephens reiterated an “equal weight” rating and issued a $390.00 price objective on shares of Molina Healthcare in a report on Thursday, April 25th. Wells Fargo & Company dropped their target price on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a research report on Monday, April 29th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $407.45.

Molina Healthcare Stock Up 0.1 %

Shares of Molina Healthcare stock opened at $292.46 on Tuesday. The company has a 50-day simple moving average of $326.83 and a two-hundred day simple moving average of $362.37. Molina Healthcare, Inc. has a 52-week low of $288.79 and a 52-week high of $423.92. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. The stock has a market capitalization of $17.14 billion, a PE ratio of 15.85, a price-to-earnings-growth ratio of 0.91 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.46 by $0.27. The firm had revenue of $9.93 billion during the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. During the same quarter in the previous year, the business earned $5.81 earnings per share. The company’s revenue was up 21.9% on a year-over-year basis. On average, analysts anticipate that Molina Healthcare, Inc. will post 23.56 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.